O manejo da epilepsia na atenção primária à saúde e o que mudou com a pandemia da COVID-19?

Julia Castelan Bastian, Gigliolle Romancini de Souza Lin, Jaime Lin, Mariana Santos Lunardi, Katia Lin

Resumo


A epilepsia é uma doença neurológica bastante comum, acometendo aproximadamente 4 milhões de pessoas no Brasil e com uma estimativa de 150.000 novos casos diagnosticados todos os anos. Uma condição tão prevalente não poderia ser manejada apenas por especialistas focais, sendo imprescindível que a Atenção Primária à Saúde (APS) exerça um papel forte e resolutivo, ordenando as redes de atenção à saúde. Neste contexto, é de fundamental importância o papel do Médico de Família e Comunidade (MFC) no diagnóstico e tratamento da condição, bem como a participação da APS, desempenhando maior articulação com os diferentes pontos de atenção, a fim de garantir a integralidade do cuidado da pessoa com epilepsia.


Palavras-chave


Epilepsia; Atenção Primária em Saúde; Medicamentos Antiepilépticos; Epilepsia Farmacorresistente

Texto completo:

PDF

Referências


Fisher RS, Acevedo C, Arzimanoglou A, Bogacz A, Cross JH, Elger CE, et al. ILAE official report: a practical clinical definition of epilepsy. Epilepsia. 2014 Apr;55(4):475-82. https://doi.org/10.1111/epi.12550

Fisher RS, Cross JH, French JA, Higurashi N, Hirsch E, Jansen FE, et al. Operational classification of seizure types by the International League Against Epilepsy: position paper of the ILAE Commission for Classification and Terminology. Epilepsia. 2017 Mar;58(4):522-30. https://doi.org/10.1111/epi.13670

Fiest KM, Sauro KM, Wiebe S, Patten SB, Kwon CS, Dykeman J, et al. Prevalence and incidence of epilepsy: a systematic review and meta-analysis of international studies. Neurology. 2017 Jan;88(3):296-303. https://doi.org/10.1212/WNL.0000000000003509

Brasil. Ministério da Saúde. Secretaria de Atenção à Saúde. Departamento de Atenção Básica. Acolhimento à demanda espontânea: queixas mais comuns na Atenção Básica / Ministério da Saúde, Secretaria de Atenção à Saúde, Departamento de Atenção Básica. – 1. ed.; 1. reimp. – Brasília: Ministério da Saúde, 2013.290 p. nil. – (Cadernos de Atenção Básica n. 28, Volume II) - Página 39. https://bvsms.saude.gov.br/bvs/publicacoes/acolhimento_demanda_espontanea_queixas_comuns_cab28v2.pdf

Epilepsy: a public health imperative. Summary. Geneva: World Health Organization; 2019 (WHO/MSD/MER/19.2). https://www.who.int/mental_health/neurology/epilepsy/report_2019/en/

Ministério da Saúde. Portaria conjunta N. 17, de 21 de junho de 2018. Protocolo clínico e diretrizes terapêuticas - Epilepsia. Acessado em 30/novembro/2020. https://www.in.gov.br/materia/-/asset_publisher/Kujrw0TZC2Mb/content/id/27391635/do1-2018-06-27-portaria-conjunta-n-17-de-21-de-junho-de-2018-27391620

Volkers N. Will the pandemic give a permanent boost to telemedicine for epilepsy? Epigraph [periódico na Internet]. 2020 [acesso em 2020 Dez 01];22(4):1-10. Disponível em: https://www.ilae.org/journals/epigraph/epigraph-vol-22-issue-4-summer-2020/will-the-pandemic-give-a-permanent-boost-to-telemedicine-for-epilepsy

French JA, Brodie MJ, Caraballo R, Devinsky O, Ding D, Jehi L, et al. Keeping people with epilepsy safe during the COVID-19 pandemic. Neurology. 2020 Jun;94(23):1032-7. https://doi.org/10.1212/WNL.0000000000009632

Devinsky O, Vezzani A, O’Brien TJ, Jette N, Scheffer IE, Curtis M, et al. Epilepsy. Nat Rev Dis Primers 2018 May;4(1):18024. https://doi.org/10.1038/nrdp.2018.24

Xu Y, Nguyen D, Mohamed A, Carcel C, Li Q, Kutlubaev MA, et al. Frequency of a false positive diagnosis of epilepsy: A systematic review of observational studies. Seizure. 2016 Oct;41(1):167–74. https://doi.org/10.1016/j.seizure.2016.08.005

Kural MA, Duez L, Hansen VS, et al. Criteria for defining interictal epileptiform discharges in EEG: a clinical validation study. Neurology. 2020 May;94(20):e2139-47. https://doi.org/10.1212/WNL.0000000000009439

Scheffer I, Berkovic S, Capovilla G, et al. ILAE classification of the epilepsies: position paper of the ILAE Commission for Classification and Terminology. Epilepsia. 2017 Apr;58(4):512-21. https://doi.org/10.1111/epi.13709

Krumholz A, Wiebe S, Gronseth GS, et al. Evidence-based guideline: management of an unprovoked first seizure in adults - report of the Guideline Development Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology. 2015 Apr;84(16):1705-13. https://doi.org/10.1212/WNL.0000000000001487

Kwan P, Brodie MJ. Early identification of refractory epilepsy. New England Journal of Medicine. 2000 Feb;342:314-9. https://www.nejm.org/doi/full/10.1056/nejm200002033420503

Glauser T, Ben-Menachem E, Bourgeois B, Cnaan A, Guerreiro C, Kalviainen R, et al. Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia. 2013 Mar;54(3):551-63. https://doi.org/10.1111/epi.12074

Abou-Khalil BW. Antiepileptic drugs. Continuum (Minneap Minn). 2016 Feb;22(1):132-56. https://journals.lww.com/continuum/Abstract/2016/02000/Antiepileptic_Drugs.12.aspx

Rizvi S, Ladino LD, Hernandez-Ronquillo L, Téllez-Zenteno JF. Epidemiology of early stages of epilepsy: risk of seizure recurrence after a first seizure. Seizure. 2017 Jul;49(1):46-53. https://doi.org/10.1016/j.seizure.2017.02.006

Mula M, Sander JW. Psychosocial aspects of epilepsy: a wider approach. BJPsych Open. 2016 Jul;2(4):270-4. https://doi.org/10.1192/bjpo.bp.115.002345

Kwan P, Arzimanoglou A, Berg AT, Brodie MJ, Allen Hauser W, Mathern G, et al. Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia. 2009 Nov;51(6):1069-77. https://doi.org/10.1111/j.1528-1167.2009.02397.x

Engel Jr J. What can we do for people with drug-resistant epilepsy? Neurology. 2016 Dec;87(23):2483-9. https://doi.org/10.1212/WNL.0000000000003407

Iyer PM, McNamara PH, Fitzgerald M, Smyth L, Dardis C, Jawad T, et al. A seizure care pathway in the emergency department: preliminary quality and safety improvements. Epilepsy Res Treat. 2012 May;273175. https://www.hindawi.com/archive/2012/273175/

Beleza P. Acute symptomatic seizures: a clinically oriented review. Neurologist. 2012 May;18(3):109-19. https://doi.org/10.1097/NRL.0b013e318251e6c3

Lavin B, Dormond C, Scantlebury MH, Frouin PY, Brodie MJ. Bridging the healthcare gap: building the case for epilepsy virtual clinics in the current healthcare environment. Epilepsy Behav. 2020 Jul;111:107262. https://doi.org/10.1016/j.yebeh.2020.107262




DOI: https://doi.org/10.32963/bcmufsc.v7i1.4532

Apontamentos

  • Não há apontamentos.


Direitos autorais 2021 Julia Castelan Bastian, Gigliolle Romancini de Souza Lin, Jaime Lin, Mariana Santos Lunardi, Katia Lin

URL da licença: https://creativecommons.org/licenses/by/3.0/